266 related articles for article (PubMed ID: 19006553)
1. Frovatriptan and data publication.
Tfelt-Hansen P
Headache; 2008 Oct; 48(9):1382-3. PubMed ID: 19006553
[No Abstract] [Full Text] [Related]
2. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan.
Al-Shekhlee A; Reed R
Neurology; 2000 Sep; 55(5):735-6. PubMed ID: 11041768
[No Abstract] [Full Text] [Related]
3. Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan.
Spierings EL
Neurology; 2000 Sep; 55(5):735; author reply 736. PubMed ID: 10980753
[No Abstract] [Full Text] [Related]
4. Efficacy of frovatriptan.
Hutchison J
Headache; 2007 Sep; 47(8):1227. PubMed ID: 17883538
[No Abstract] [Full Text] [Related]
5. Efficacy of frovatriptan.
Tfelt-Hansen P
Headache; 2007 Jun; 47(6):934; discussion 934. PubMed ID: 17578554
[No Abstract] [Full Text] [Related]
6. [Frovatriptan. For treatment of acute migraine].
Taéron C
Rev Infirm; 2010; (157):47-9. PubMed ID: 20198950
[No Abstract] [Full Text] [Related]
7. Unilateral time-delayed encapsulation does not make for a fair race.
Loftus BD
Headache; 2003 Sep; 43(8):921; author reply 924-8. PubMed ID: 12940818
[No Abstract] [Full Text] [Related]
8. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
Brandes JL; Poole Ac; Kallela M; Schreiber CP; MacGregor EA; Silberstein SD; Tobin J; Shaw R
Cephalalgia; 2009 Nov; 29(11):1133-48. PubMed ID: 19811503
[TBL] [Abstract][Full Text] [Related]
9. Musing on Mathew et al.
Kaniecki RG
Headache; 2003 Sep; 43(8):922; author reply 924-8. PubMed ID: 14562838
[No Abstract] [Full Text] [Related]
10. Comparison of rizatriptan and sumatriptan.
O'Quinn S; Mansbach H; Salonen R
Headache; 1999 Jan; 39(1):59-60. PubMed ID: 18567177
[No Abstract] [Full Text] [Related]
11. Frovatriptan Vernalis.
Mucke HA
Curr Opin Investig Drugs; 2002 Sep; 3(9):1373-80. PubMed ID: 12498015
[TBL] [Abstract][Full Text] [Related]
12. Frovatriptan use in migraineurs with or at high risk of coronary artery disease.
Elkind AH; Satin LZ; Nila A; Keywood C
Headache; 2004 May; 44(5):403-10. PubMed ID: 15147247
[TBL] [Abstract][Full Text] [Related]
13. Almotriptan (Axert) and frovatriptan (Frova) for migrane.
Med Lett Drugs Ther; 2002 Feb; 44(1124):19-20. PubMed ID: 11856954
[No Abstract] [Full Text] [Related]
14. [Migraine therapy. new specific triptan frovatriptan--long acting].
Schmerz; 2003 Jan; 17(1):2p following 97. PubMed ID: 12638532
[No Abstract] [Full Text] [Related]
15. Triptan therapy in migraine.
Loder E
N Engl J Med; 2010 Jul; 363(1):63-70. PubMed ID: 20592298
[No Abstract] [Full Text] [Related]
16. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
Elkind AH; MacGregor EA
Expert Rev Neurother; 2008 May; 8(5):723-36. PubMed ID: 18457529
[TBL] [Abstract][Full Text] [Related]
17. [Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible].
MMW Fortschr Med; 2007 May; 149 Suppl 2():102-3. PubMed ID: 17724980
[No Abstract] [Full Text] [Related]
18. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
MacGregor EA; Pawsey SP; Campbell JC; Hu X
Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
[TBL] [Abstract][Full Text] [Related]
20. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
Balbisi EA
Int J Clin Pract; 2004 Jul; 58(7):695-705. PubMed ID: 15311727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
